Precision NanoSystems and Replicate Bioscience in licensing deal to scale up genomic medicines - Canada NewsWire

/CNW/ -- In a move that signifies the heightened focus on mRNA as a key tool in human health, Precision NanoSystems (PNI) and Replicate Bioscience will enter a...

- Companies aim to support development of up to 15 new genomic medicine products - Replicate's commercial licensing of lipid nanoparticle technology from Precision NanoSystems at foundation of deal … [+3990 chars]

full article...